GREAT POINT PARTNERS LLC 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:45 pm Sale |
2024-09-30 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 0 0.000% |
-3,703,433 (Position Closed) |
Filing |
| 2024-02-14 4:36 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,703,433 6.370% |
65,715 (+1.81%) |
Filing |
| 2023-02-14 4:57 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,637,718 7.920% |
189,197 (+5.49%) |
Filing |
| 2022-09-30 09:37 am Purchase |
2022-09-21 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,448,521 7.850% |
3,448,521 (New Position) |
Filing |